Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy
Nom du journal : J Clin Oncol
Année : 2013
Volume : 31
Page de départ : 2485
Page de fin : 2492